(Q42981430)

12 November 2017

title

Long-term interferon monotherapy reduces the risk of HCV-associated hepatocellular carcinoma (English)

1 reference

12 November 2017

13

Hiromitsu Kumada

1 reference

12 November 2017

3

Fumitaka Suzuki

1 reference

12 November 2017

12

Kenji Ikeda

1 reference

12 November 2017

9

Masahiro Kobayashi

1 reference

12 November 2017

7

Yoshiyuki Suzuki

1 reference

12 November 2017

2

Norio Akuta

1 reference

12 November 2017

11

Yasuji Arase

1 reference

12 November 2017

6

Hitomi Sezaki

1 reference

12 November 2017

5

Yusuke Kawamura

1 reference

12 November 2017

10

Mariko Kobayashi

1 reference

12 November 2017

8

Tetsuya Hosaka

1 reference

12 November 2017

Makiko Takeyasu

1

1 reference

12 November 2017

Yuya Seko

series ordinal

4

1 reference

12 November 2017

publication date

1 August 2012

1 reference

Journal of Medical Virology

12 November 2017

published in

1 reference

12 November 2017

volume

84

1 reference

12 November 2017

issue

8

1 reference

12 November 2017

page(s)

1199-1207

1 reference

Association of amino acid substitution pattern in core protein of hepatitis C virus genotype 1b high viral load and non-virological response to interferon-ribavirin combination therapy.

12 November 2017

cites work

1 reference

Predictive factors of early and sustained responses to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b: amino acid substitutions in the core region and low-density lipoprotein cholest

21 January 2018

1 reference

Amino acid substitutions in the hepatitis C virus core region are the important predictor of hepatocarcinogenesis.

21 January 2018

1 reference

Efficacy of low-dose intermittent interferon-alpha monotherapy in patients infected with hepatitis C virus genotype 1b who were predicted or failed to respond to pegylated interferon plus ribavirin combination therapy

21 January 2018

1 reference

Amino acid substitution in hepatitis C virus core region and genetic variation near the interleukin 28B gene predict viral response to telaprevir with peginterferon and ribavirin.

21 January 2018

1 reference

Prolonged-interferon therapy reduces hepatocarcinogenesis in aged-patients with chronic hepatitis C.

21 January 2018

1 reference

IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypes

21 January 2018

1 reference

Hepatitis C virus genotype 1b as a major risk factor associated with hepatocellular carcinoma in patients with cirrhosis: a seventeen-year prospective cohort study

21 January 2018

1 reference

Genotypic subtyping of hepatitis C virus

21 January 2018

1 reference

Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma

21 January 2018

1 reference

Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection

21 January 2018

1 reference

Mutations in the hepatitis C virus core gene are associated with advanced liver disease and hepatocellular carcinoma

21 January 2018

1 reference

Estimating progression to cirrhosis in chronic hepatitis C virus infection.

21 January 2018

1 reference

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

21 January 2018

1 reference

High amino acid variability within the NS5A of hepatitis C virus (HCV) is associated with hepatocellular carcinoma in patients with HCV-1b-related cirrhosis.

21 January 2018

1 reference

Hepatic steatosis in chronic hepatitis C is a significant risk factor for developing hepatocellular carcinoma independent of age, sex, obesity, fibrosis stage and response to interferon therapy.

21 January 2018

1 reference

Characteristic mutations in hepatitis C virus core gene related to the occurrence of hepatocellular carcinoma

21 January 2018

1 reference

Effect of interferon therapy on hepatocellular carcinogenesis in patients with chronic hepatitis type C: A long-term observation study of 1,643 patients using statistical bias correction with proportional hazard analysis.

21 January 2018

1 reference

Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis

21 January 2018

1 reference

Diabetes enhances hepatocarcinogenesis in noncirrhotic, interferon-treated hepatitis C patients.

21 January 2018

1 reference

Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group

21 January 2018

1 reference

Molecular basis of hepatitis C virus-associated hepatocarcinogenesis: lessons from animal model studies

21 January 2018

1 reference

Lipid metabolism and liver disease in hepatitis C viral infection

21 January 2018

1 reference

Maintenance peginterferon therapy and other factors associated with hepatocellular carcinoma in patients with advanced hepatitis C

21 January 2018

1 reference

Association of diabetes mellitus and chronic hepatitis C virus infection.

21 January 2018

1 reference

Clinical trial: interferon alpha-2b continuous long-term therapy vs. repeated 24-week cycles for re-treating chronic hepatitis C.

21 January 2018

1 reference

Proteasome activator PA28gamma-dependent nuclear retention and degradation of hepatitis C virus core protein

21 January 2018

1 reference

Critical role of PA28 in hepatitis C virus-associated steatogenesis and hepatocarcinogenesis

21 January 2018

1 reference

The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice

21 January 2018

1 reference

Association between mutations in the core region of hepatitis C virus genotype 1 and hepatocellular carcinoma development

21 January 2018

1 reference

Prognosis of chronic hepatitis C: results of a large, prospective cohort study.

21 January 2018

1 reference

Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis.

21 January 2018

1 reference

Efficacy of low dose long-term interferon monotherapy in aged patients with chronic hepatitis C genotype 1 and its relation to alpha-fetoprotein: A pilot study.

21 January 2018

1 reference

Identification of Hepatitis C Virus (HCV) Subtype 1b Strains That Are Highly, or Only Weakly, Associated with Hepatocellular Carcinoma on the Basis of the Secondary Structure of an Amino-Terminal Portion of the HCV NS3 Protein

21 January 2018

1 reference

Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection

21 January 2018

1 reference

The impact of obesity and diabetes mellitus on the risk of hepatocellular carcinoma.

21 January 2018

1 reference

Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study

21 January 2018

1 reference

Impact of amino acid substitutions in hepatitis C virus genotype 1b core region on liver steatosis and glucose tolerance in non-cirrhotic patients without overt diabetes

21 January 2018

1 reference

IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy

21 January 2018

1 reference

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C

21 January 2018

1 reference

Early viral kinetics and treatment outcome in combination of high-dose interferon induction vs. pegylated interferon plus ribavirin for naive patients infected with hepatitis C virus of genotype 1b and high viral load.

21 January 2018

1 reference

Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of Hepatocarcinogenesis by Interferon Therapy.

21 January 2018

1 reference

IL-28B rs12979860 C/T allele distribution in patients with liver cirrhosis: Role in the course of chronic viral hepatitis and the development of HCC

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JMV.23288

1 reference

12 November 2017

1 reference